Scilex Holding Co
For the period ended Mar 31, 2024. Filed May 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 13, 2024
SCLX$1.74+2.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
(In thousands, except for share and net loss per share amounts)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Net revenue | $10,884 | $10,582 |
| Operating costs and expenses: | ||
| Cost of revenue | 3,840 | 3,591 |
| Research and development | 3,108 | 2,736 |
| Selling, general and administrative | 29,278 | 28,701 |
| Intangible amortization | 1,027 | 1,027 |
| Legal settlements | (6,891) | — |
| Total operating costs and expenses | 30,362 | 36,055 |
| Loss from operations | (19,478) | (25,473) |
| Other (income) expense: | ||
| Loss on derivative liability | 457 | 5,253 |
| Change in fair value of debt and liability instruments | 3,905 | — |
| Interest expense, net | 531 | (1) |
| Loss on foreign currency exchange | 6 | 20 |
| Total other expense | 4,899 | 5,272 |
| Loss before income taxes | (24,377) | (30,745) |
| Income tax expense | — | 8 |
| Net loss | $(24,377) | $(30,753) |
| Net loss per share attributable to common stockholders — basic and diluted | $(0.24) | $(0.22) |
| Weighted average number of shares during the period — basic and diluted | 102,407 | 141,660 |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
(In thousands)
| Preferred Stock · Common Stock · Additional · Accumulated · Treasury Stock · Stockholders’ | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Paid-in Capital | Deficit | Shares | Amount | Deficit | |
| Balance, December 31, 2023 | 29,057 | — | 160,084 | $16 | $407,813 | $(490,245) | 60,069 | $(90,522) | $(172,938) |
| Shares issued under Standby Equity Purchase Agreements and under ATM Sales Agreement | — | — | 189 | — | 156 | — | — | — | 156 |
| Shares issued under Bought Deal Offering | — | — | 5,882 | 1 | 3,768 | — | — | — | 3,769 |
| Stock options exercised | — | — | 35 | — | 46 | — | — | — | 46 |
| Stock-based compensation | — | — | — | — | 3,558 | — | — | — | 3,558 |
| Net loss | — | — | — | — | — | (24,377) | — | — | (24,377) |
| Balance, March 31, 2024 | 29,057 | $— | 166,190 | $17 | $415,341 | $(514,622) | 60,069 | $(90,522) | $(189,786) |
| Preferred Stock · Common Stock · Additional · Accumulated · Treasury Stock · Stockholders’ | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Paid-in Capital | Deficit | Shares | Amount | Deficit | |
| Balance, December 31, 2022 | 29,057 | $3 | 141,349 | $14 | $412,136 | $(375,914) | — | $— | $36,239 |
| Shares issued under Standby Equity Purchase Agreements | — | — | 462 | — | 1,869 | — | — | — | 1,869 |
| Retainer shares issued | — | — | 4,000 | 1 | — | — | — | — | 1 |
| Stock-based compensation | — | — | — | — | 3,720 | — | — | — | 3,720 |
| Net loss | — | — | — | — | — | (30,753) | — | — | (30,753) |
| Balance, March 31, 2023 | 29,057 | $3 | 145,811 | $15 | $417,725 | $(406,667) | — | $— | $11,076 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.